Similar articles

• Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].

  Howlett DR, Morris H, Nahorski SR. Howlett DR, et al. Br J Pharmacol. 1979 May;66(1):136P. Br J Pharmacol. 1979. PMID: 454928 Free PMC article. No abstract available.
• Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?

  Clements-Jewery S, Robson PA. Clements-Jewery S, et al. Neuropharmacology. 1981 Dec;20(12B):1295-8. Neuropharmacology. 1981. PMID: 7322304 No abstract available.
• [3H]spiperone binding sites in rat primary glial cultures, C6 glioma, and B104 neuroblastoma.

  Severson JA, de Vellis JS, Finch CE. Severson JA, et al. J Neurosci Res. 1983;9(1):21-6. doi: 10.1002/jnr.490090104. J Neurosci Res. 1983. PMID: 6834436
• Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.

  Zahniser NR, Dubocovich ML. Zahniser NR, et al. J Pharmacol Exp Ther. 1983 Dec;227(3):592-9. J Pharmacol Exp Ther. 1983. PMID: 6655559
• Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.

  Hancock AA, Marsh CL. Hancock AA, et al. Mol Pharmacol. 1984 Nov;26(3):439-51. Mol Pharmacol. 1984. PMID: 6238230